Search - tctmd.com

Displaying 21 - 40 of 51

Sort: Relevancy | Date

Presentation TCT 2019

TAVR in Bicuspid Aortic Valves

Presenter: Lars Sondergaard

September 25, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

Presentation TVT 2019

Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

Presenter: Vinod Thourani

June 13, 2019

Presentation TVT 2019

Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Presenter: Christopher Meduri

June 13, 2019

Presentation TVT 2019

Treating Bicuspid Valves With Current Transcatheter Valve Platforms

Presenter: Didier Tchetche

June 13, 2019

Presentation TVT 2019

Treating AR With Current Transcatheter Valve Platforms

Presenter: David Muller

June 13, 2019

Presentation TVT 2019

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2019

Latest Clinical Data in Bicuspid Disease

Presenter: John Forrest

June 13, 2019

Presentation TVT 2019

CT Assessment for Bicuspid Valve TAVR. Annular or Supra-Annular Sizing? Coronary Access? TAVR Repeatability?

Presenter: Philipp Blanke

June 13, 2019

Presentation TVT 2019

Case: JenaValve for Pure Aortic Regurgitation

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Case: J-Valve for Pure Aortic Regurgitation

Presenter: Jian Ye

June 13, 2019

Presentation TVT 2019

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Howard Herrmann

June 13, 2019

Presentation TVT 2019

TAVR in Bicuspid Valve: Learning the Hard Way

Presenter: Nagendra Chouhan

June 13, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

Presentation

Association Between TAVR for Bicuspid vs Tricuspid Aortic Stenosis and Mortality and Stroke

June 11, 2019

News Conference News EuroPCR 2019

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

Caitlin E. Cox

May 24, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Industry News

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

May 07, 2019

Advertisement

TAVR in Bicuspid Aortic Valves

FDA Expands TAVR Indication to Low-Risk Patients

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

Better for Bicuspids and Dry Leaflet Technology

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Treating Bicuspid Valves With Current Transcatheter Valve Platforms

Treating AR With Current Transcatheter Valve Platforms

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Latest Clinical Data in Bicuspid Disease

CT Assessment for Bicuspid Valve TAVR. Annular or Supra-Annular Sizing? Coronary Access? TAVR Repeatability?

Case: JenaValve for Pure Aortic Regurgitation

Case: J-Valve for Pure Aortic Regurgitation

A Clinical Algorithm for Diagnosing and Managing Patients With Low-Flow, Low-Gradient Aortic Stenosis

TAVR in Bicuspid Valve: Learning the Hard Way

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Association Between TAVR for Bicuspid vs Tricuspid Aortic Stenosis and Mortality and Stroke

TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content